Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP380419.RAM1kZjO8tWXBILUDe2kOtowH7DCl92pONePP1VD7ahcw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP380419.RAM1kZjO8tWXBILUDe2kOtowH7DCl92pONePP1VD7ahcw130_assertion type Assertion NP380419.RAM1kZjO8tWXBILUDe2kOtowH7DCl92pONePP1VD7ahcw130_head.
- NP380419.RAM1kZjO8tWXBILUDe2kOtowH7DCl92pONePP1VD7ahcw130_assertion description "[Three of 8 clear (38%) cell carcinomas and 7 of 25 serous carcinomas (28%) screened exhibited HER2 amplification compared with 7% (2/29) of endometrioid adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380419.RAM1kZjO8tWXBILUDe2kOtowH7DCl92pONePP1VD7ahcw130_provenance.
- NP380419.RAM1kZjO8tWXBILUDe2kOtowH7DCl92pONePP1VD7ahcw130_assertion evidence source_evidence_literature NP380419.RAM1kZjO8tWXBILUDe2kOtowH7DCl92pONePP1VD7ahcw130_provenance.
- NP380419.RAM1kZjO8tWXBILUDe2kOtowH7DCl92pONePP1VD7ahcw130_assertion SIO_000772 19840887 NP380419.RAM1kZjO8tWXBILUDe2kOtowH7DCl92pONePP1VD7ahcw130_provenance.
- NP380419.RAM1kZjO8tWXBILUDe2kOtowH7DCl92pONePP1VD7ahcw130_assertion wasDerivedFrom befree-20150227 NP380419.RAM1kZjO8tWXBILUDe2kOtowH7DCl92pONePP1VD7ahcw130_provenance.
- NP380419.RAM1kZjO8tWXBILUDe2kOtowH7DCl92pONePP1VD7ahcw130_assertion wasGeneratedBy ECO_0000203 NP380419.RAM1kZjO8tWXBILUDe2kOtowH7DCl92pONePP1VD7ahcw130_provenance.